4
Changes in Ownership
Nautilus Biotechnology, Inc. Filed Acc 0001062993-21-011100
Director bought 100,000 shares at $5.30 ($529,890)
From the SEC's structured data for this filing
Trades in this filing
McIlwain Matthew S · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-11-15 | Purchase : show line 1 in the form | +100,000 | $5.30 | $529,890 | 459,075 | D |
| Open-market purchases · 100,000 sh · avg $5.30 · $529,890 | ||||||
Loading xslF345X03/form4.xml…